Doxorubicin-induced cardiotoxicity is mediated by impaired lysosomal acidification and blocked autophagic flux, suggesting that reducing autophagy initiation may offer a protective strategy.
Doxorubicin blocks autophagic flux in cardiomyocytes by impairing lysosome acidification and lysosomal function. Reducing autophagy initiation protects against doxorubicin cardiotoxicity.
Li et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: